Literature DB >> 31258804

CLINICALLY UNDETECTABLE OCCULT THYROID PAPILLARY CARCINOMA PRESENTING WITH CERVICAL LYMPH NODE METASTASIS.

E Tastekin1, N Can1, S Ayturk2, M Celik2, F Ustun3, S Guldiken2, A Sezer4, H Celik2, M Koten5.   

Abstract

BACKGROUND: Occult papillary thyroid carcinoma presented as isolated cervical lymphadenopathy without clinical and radiologic findings has been rarely reported. CASE REPORT: A 47 years old female patient admitted to otorhinolaryngology clinic with 4X3 cm sized cervical mass. Physical examination of the patient was noted as a nontender, firm, mobile lymph node at right lateral cervical region. There was no inflammatory or infection disease in the history of patients anamnesis and no abnormal value on laboratory tests. Ultrasound screening of the neck detected a lymph node with suspicious features for malignancy. Head and neck examination was normal and there is no evidence of a tumoral mass or nodule in the thyroid gland. Whole body scan of MRI showed no pathologic sign both in the neck and body. Excisional biopsy was performed and revealed a carcinoma with papillary morphology. Immunohistochemical staining features of the tumor confirmed a papillary carcinoma derived from the thyroid gland. Second look USG of the neck and thyroid was performed but it revealed no tumoral mass. The patient underwent total thyroidectomy with right functional and central lymph node dissection. Histological examination of the thyroid gland showed multicentric 2 mm sized, three foci of papillary carcinoma located in bilateral thyroid lobes and metastatic lymph nodes in the right side of the neck.
CONCLUSION: A metastatic cervical lymph node can be evidence of a clinically undetected occult papillary thyroid carcinoma. Specific immunohistochemistry staining of specimen may lead to appropriate surgery and progression of carcinoma may be hindered by application of additional RAI therapy.

Entities:  

Keywords:  Thyroid; occult carcinoma; papillary carcinoma; papillary micro-carcinoma

Year:  2016        PMID: 31258804      PMCID: PMC6586761          DOI: 10.4183/aeb.2016.72

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  18 in total

1.  The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.

Authors:  Kuai-Lu Lin; Ou-Chen Wang; Xiao-Hua Zhang; Xuan-Xuan Dai; Xiao-Qu Hu; Jin-Miao Qu
Journal:  Ann Surg Oncol       Date:  2010-10-15       Impact factor: 5.344

2.  Papillary thyroid carcinoma.

Authors:  I D Hay
Journal:  Endocrinol Metab Clin North Am       Date:  1990-09       Impact factor: 4.741

3.  Cervical lymph node metastasis and papillary thyroid carcinoma: does the compartment involved affect survival? Experience from the SEER database.

Authors:  Valerie A Smith; Roy B Sessions; Eric J Lentsch
Journal:  J Surg Oncol       Date:  2012-03-05       Impact factor: 3.454

4.  Risk factors contributing to the difference in prognosis for papillary versus micropapillary thyroid carcinoma.

Authors:  Theodore Karatzas; Ioannis Vasileiadis; Stylianos Kapetanakis; Efthimios Karakostas; George Chrousos; Gregory Kouraklis
Journal:  Am J Surg       Date:  2013-06-19       Impact factor: 2.565

5.  Incidence and histopathological behavior of papillary microcarcinomas: study of 429 cases.

Authors:  Michael N Pakdaman; Louise Rochon; Olguta Gologan; Michael Tamilia; Natasha Garfield; Michael P Hier; Martin J Black; Richard J Payne
Journal:  Otolaryngol Head Neck Surg       Date:  2008-11       Impact factor: 3.497

6.  Performance of preoperative sonographic staging of papillary thyroid carcinoma based on the sixth edition of the AJCC/UICC TNM classification system.

Authors:  Jeong Seon Park; Kyu-Ri Son; Dong Gyu Na; Eunhee Kim; Sungjun Kim
Journal:  AJR Am J Roentgenol       Date:  2009-01       Impact factor: 3.959

7.  Papillary microcarcinoma of the thyroid: clinical characteristics and BRAF(V600E) mutational status of 977 cases.

Authors:  Xiangqian Zheng; Songfeng Wei; Ying Han; Yancong Li; Yang Yu; Xinwei Yun; Xiubao Ren; Ming Gao
Journal:  Ann Surg Oncol       Date:  2013-01-31       Impact factor: 5.344

8.  Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer.

Authors:  Ji Eun Ahn; Jeong Hyun Lee; Jong Sook Yi; Young Ki Shong; Seok Joon Hong; Deok Hee Lee; Choong Gon Choi; Sang Joon Kim
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

9.  Prognosis of multifocal papillary thyroid carcinoma.

Authors:  Sheng-Fong Kuo; Shu-Fu Lin; Tzu-Chieh Chao; Chuen Hsueh; Kun-Ju Lin; Jen-Der Lin
Journal:  Int J Endocrinol       Date:  2013-12-30       Impact factor: 3.257

10.  Metastatic papillary thyroid carcinoma with absence of tumor focus in thyroid gland.

Authors:  Anil Singh; Radu Butuc; Ricardo Lopez
Journal:  Am J Case Rep       Date:  2013-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.